Free

Karen Knudsen, enterprise director of the Sidney Kimmel Cancer Center–Jefferson Health, was elected vice president/president-elect of the Association of American Cancer Institutes' board of directors.

Cory Wiegert was named chief executive officer of CancerLinQ LLC, a non-profit subsidiary of the American Society of Clinical Oncology.

Moffitt Cancer Center's chief information security officer will join a group of experts charged with protecting and enhancing national cybersecurity.

Exact Sciences Corp. and Pfizer Inc. announced an agreement through 2021 to co-promote Cologuard, the only FDA-approved non-invasive stool DNA screening test for colorectal cancer. Pfizer will join the Exact Sciences sales representatives in reaching both physicians and health systems and will also actively participate in extending and deepening the Cologuard marketing campaign.

MD Anderson Cancer Center and Accelerator Life Science Partners announced the launch of Magnolia Neurosciences Corp., a company developing a new class of neuroprotective medicines, with $31 million in Series A funding. The company will develop novel therapeutics based on discoveries made by researchers in MD Anderson's Therapeutics Discovery division, including the Institute for Applied Cancer Science and the Neurodegeneration Consortium.

Members of the UCLA urology department received $9.3 million of funding from the state of California to help combat the financial burden of cancer treatment for men diagnosed with prostate cancer.

Ana María López joined the Sidney Kimmel Cancer Center–Jefferson Health as the vice chair of medical oncology and chief of cancer services at the Sidney Kimmel Cancer Center–Washington Township.

Fox Chase Cancer Center has hired Julio Noriega as an assistant professor in the Division of Pulmonary, Critical Care, and Sleep Medicine.

Cancer Treatment Centers of America Global Inc. announced enterprise-wide promotions: